Comparative genomic hybridization

Donna G. Albertson, Daniel Pinkel

Research output: Chapter in Book/Report/Conference proceedingChapter

Abstract

Cells progress to cancer by the acquisition of genetic and epigenetic alterations that promote growth and survival. The genomic alterations range from mutations in individual nucleotides to rearrangements and changes in the copy number of chromosomal segments or whole chromosomes. The former result in point mutations that inactivate tumor suppressor genes or activate oncogenes, and the latter produce novel fusion genes and/or alter the expression of one or more genes that may individually or co-operatively modify cell behavior. The technique of comparative genomic hybridization (CGH) was first introduced in 1992 as a means to assess copy number changes in genomes (1). In the original implementation of CGH, a test genomic DNA, such as DNA extracted from a tumor, and a reference DNA, typically genomic DNA from normal cells, were differentially labeled and then hybridized to normal metaphase chromosomes. The chromosomes provided a readily available physical map of the genome. For mammalian genomes it is important to suppress the hybridization of the large number of repetitive sequences. This is typically done by including an excess of unlabeled repetitive DNA (Cot-1 DNA) in the hybridization reaction. Measurement of the relative intensities of the hybridization of the test and reference genomes along the metaphase chromosomes provides a profile of the relative copy number of sequences in the test and reference genomes. Chromosome CGH provided genomic resolution on the order of 10 Mb. Starting in the late 1990s, the physical map provided by metaphase chromosomes was superseded by arrays of mapped genomic clones (2,3), cDNAs, and more recently oligonucleotides, and the technique became known as “array CGH” to distinguish it from CGH using metaphase chromosomes (Figure 3.1).

Original languageEnglish (US)
Title of host publicationMolecular oncology
Subtitle of host publicationCauses of cancer and targets for treatment
EditorsE Gelman, C Sawyers, F Rauscher
PublisherCambridge University Press
Pages21-27
Number of pages7
ISBN (Print)9781139046947, 9780521876629
DOIs
StatePublished - Jan 1 2015

Fingerprint

Comparative Genomic Hybridization
Chromosomes
Metaphase
Genome
DNA
Nucleic Acid Repetitive Sequences
Gene Fusion
Tumor Suppressor Genes
Oncogenes
Point Mutation
Epigenomics
Oligonucleotides
Neoplasms
Nucleotides
Complementary DNA
Clone Cells
Mutation
Growth
Genes

ASJC Scopus subject areas

  • Medicine(all)

Cite this

Albertson, D. G., & Pinkel, D. (2015). Comparative genomic hybridization. In E. Gelman, C. Sawyers, & F. Rauscher (Eds.), Molecular oncology: Causes of cancer and targets for treatment (pp. 21-27). Cambridge University Press. https://doi.org/10.1017/CBO9781139046947.004

Comparative genomic hybridization. / Albertson, Donna G.; Pinkel, Daniel.

Molecular oncology: Causes of cancer and targets for treatment. ed. / E Gelman; C Sawyers; F Rauscher. Cambridge University Press, 2015. p. 21-27.

Research output: Chapter in Book/Report/Conference proceedingChapter

Albertson, DG & Pinkel, D 2015, Comparative genomic hybridization. in E Gelman, C Sawyers & F Rauscher (eds), Molecular oncology: Causes of cancer and targets for treatment. Cambridge University Press, pp. 21-27. https://doi.org/10.1017/CBO9781139046947.004
Albertson DG, Pinkel D. Comparative genomic hybridization. In Gelman E, Sawyers C, Rauscher F, editors, Molecular oncology: Causes of cancer and targets for treatment. Cambridge University Press. 2015. p. 21-27 https://doi.org/10.1017/CBO9781139046947.004
Albertson, Donna G. ; Pinkel, Daniel. / Comparative genomic hybridization. Molecular oncology: Causes of cancer and targets for treatment. editor / E Gelman ; C Sawyers ; F Rauscher. Cambridge University Press, 2015. pp. 21-27
@inbook{1efb679d5c0e4a5594abbb53722fee19,
title = "Comparative genomic hybridization",
abstract = "Cells progress to cancer by the acquisition of genetic and epigenetic alterations that promote growth and survival. The genomic alterations range from mutations in individual nucleotides to rearrangements and changes in the copy number of chromosomal segments or whole chromosomes. The former result in point mutations that inactivate tumor suppressor genes or activate oncogenes, and the latter produce novel fusion genes and/or alter the expression of one or more genes that may individually or co-operatively modify cell behavior. The technique of comparative genomic hybridization (CGH) was first introduced in 1992 as a means to assess copy number changes in genomes (1). In the original implementation of CGH, a test genomic DNA, such as DNA extracted from a tumor, and a reference DNA, typically genomic DNA from normal cells, were differentially labeled and then hybridized to normal metaphase chromosomes. The chromosomes provided a readily available physical map of the genome. For mammalian genomes it is important to suppress the hybridization of the large number of repetitive sequences. This is typically done by including an excess of unlabeled repetitive DNA (Cot-1 DNA) in the hybridization reaction. Measurement of the relative intensities of the hybridization of the test and reference genomes along the metaphase chromosomes provides a profile of the relative copy number of sequences in the test and reference genomes. Chromosome CGH provided genomic resolution on the order of 10 Mb. Starting in the late 1990s, the physical map provided by metaphase chromosomes was superseded by arrays of mapped genomic clones (2,3), cDNAs, and more recently oligonucleotides, and the technique became known as “array CGH” to distinguish it from CGH using metaphase chromosomes (Figure 3.1).",
author = "Albertson, {Donna G.} and Daniel Pinkel",
year = "2015",
month = "1",
day = "1",
doi = "10.1017/CBO9781139046947.004",
language = "English (US)",
isbn = "9781139046947",
pages = "21--27",
editor = "E Gelman and C Sawyers and F Rauscher",
booktitle = "Molecular oncology",
publisher = "Cambridge University Press",

}

TY - CHAP

T1 - Comparative genomic hybridization

AU - Albertson, Donna G.

AU - Pinkel, Daniel

PY - 2015/1/1

Y1 - 2015/1/1

N2 - Cells progress to cancer by the acquisition of genetic and epigenetic alterations that promote growth and survival. The genomic alterations range from mutations in individual nucleotides to rearrangements and changes in the copy number of chromosomal segments or whole chromosomes. The former result in point mutations that inactivate tumor suppressor genes or activate oncogenes, and the latter produce novel fusion genes and/or alter the expression of one or more genes that may individually or co-operatively modify cell behavior. The technique of comparative genomic hybridization (CGH) was first introduced in 1992 as a means to assess copy number changes in genomes (1). In the original implementation of CGH, a test genomic DNA, such as DNA extracted from a tumor, and a reference DNA, typically genomic DNA from normal cells, were differentially labeled and then hybridized to normal metaphase chromosomes. The chromosomes provided a readily available physical map of the genome. For mammalian genomes it is important to suppress the hybridization of the large number of repetitive sequences. This is typically done by including an excess of unlabeled repetitive DNA (Cot-1 DNA) in the hybridization reaction. Measurement of the relative intensities of the hybridization of the test and reference genomes along the metaphase chromosomes provides a profile of the relative copy number of sequences in the test and reference genomes. Chromosome CGH provided genomic resolution on the order of 10 Mb. Starting in the late 1990s, the physical map provided by metaphase chromosomes was superseded by arrays of mapped genomic clones (2,3), cDNAs, and more recently oligonucleotides, and the technique became known as “array CGH” to distinguish it from CGH using metaphase chromosomes (Figure 3.1).

AB - Cells progress to cancer by the acquisition of genetic and epigenetic alterations that promote growth and survival. The genomic alterations range from mutations in individual nucleotides to rearrangements and changes in the copy number of chromosomal segments or whole chromosomes. The former result in point mutations that inactivate tumor suppressor genes or activate oncogenes, and the latter produce novel fusion genes and/or alter the expression of one or more genes that may individually or co-operatively modify cell behavior. The technique of comparative genomic hybridization (CGH) was first introduced in 1992 as a means to assess copy number changes in genomes (1). In the original implementation of CGH, a test genomic DNA, such as DNA extracted from a tumor, and a reference DNA, typically genomic DNA from normal cells, were differentially labeled and then hybridized to normal metaphase chromosomes. The chromosomes provided a readily available physical map of the genome. For mammalian genomes it is important to suppress the hybridization of the large number of repetitive sequences. This is typically done by including an excess of unlabeled repetitive DNA (Cot-1 DNA) in the hybridization reaction. Measurement of the relative intensities of the hybridization of the test and reference genomes along the metaphase chromosomes provides a profile of the relative copy number of sequences in the test and reference genomes. Chromosome CGH provided genomic resolution on the order of 10 Mb. Starting in the late 1990s, the physical map provided by metaphase chromosomes was superseded by arrays of mapped genomic clones (2,3), cDNAs, and more recently oligonucleotides, and the technique became known as “array CGH” to distinguish it from CGH using metaphase chromosomes (Figure 3.1).

UR - http://www.scopus.com/inward/record.url?scp=84954134743&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84954134743&partnerID=8YFLogxK

U2 - 10.1017/CBO9781139046947.004

DO - 10.1017/CBO9781139046947.004

M3 - Chapter

AN - SCOPUS:84954134743

SN - 9781139046947

SN - 9780521876629

SP - 21

EP - 27

BT - Molecular oncology

A2 - Gelman, E

A2 - Sawyers, C

A2 - Rauscher, F

PB - Cambridge University Press

ER -